PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Dec-2025 Medable Launches Innovation Evidence Workshop – First Collaboration To Bring Leaders Together on DCT Impact, Adoption, and Best Practices Businesswire
10-Dec-2025 CLS Health Strengthens Its Community Care Network in Southeast Houston and Pasadena ACCESS Newswire
10-Dec-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Dec-2025 Coulter Partners continues strategic reorganization to drive global growth and innovation Coulter Partners
10-Dec-2025 First Patient Dosed in Part 2 of Modus Therapeutics’ Phase IIa Study in Chronic Kidney Disease with Anemia Modus Therapeutics
10-Dec-2025 Lack of education causes patients to stop vital treatments, survey finds Cognitant Group Ltd
10-Dec-2025 PLL Therapeutics opens subsidiary in New Zealand to accelerate ALS (Amyotrophic Lateral Sclerosis) treatment and early diagnostics breakthroughs PLL Therapeutics
10-Dec-2025 Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator Businesswire
10-Dec-2025 Poxel Publishes Its Financial Results for the First Half of 2025 Businesswire
10-Dec-2025 L&T Technology Services, PALFINGER Inaugurate GDC as Part of Multi-Year Engagement to Accelerate Product Development Businesswire
10-Dec-2025 Veterinary Lasers Market Trend Insights | How New Developments Are Shaping The Healthcare Sector Medi-Tech Insights
10-Dec-2025 Future Prospects: Key Trends Shaping the Pericarditis Single-Use Surgical Instruments Market Up to 2030 Medi-Tech Insights
10-Dec-2025 Sinceri Senior Living Expands Texas Presence Through New Partnership with CareTrust REIT ACCESS Newswire
10-Dec-2025 PLL Therapeutics opens subsidiary in New Zealand to accelerate ALS (Amyotrophic Lateral Sclerosis) treatment and early diagnostics breakthroughs Andrew Lloyd Associates
10-Dec-2025 Bariatric Surgery Devices Market Insights | Leading Companies and New Entrants in the Healthcare Sector Medi-Tech Insights
10-Dec-2025 Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility Igyxos Biotherapeutics
10-Dec-2025 Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility Igyxos Biotherapeutics
10-Dec-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Real Game Used Achieves Major Milestone in High-End Memorabilia Authentication ACCESS Newswire
10-Dec-2025 Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases Businesswire
10-Dec-2025 IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." ACCESS Newswire